Article Versions Notes

Ortega-Ayala A, de la Cruz CG, Mora L, Bonilla M, Tana L, Rodrigues-Soares F, Dorado P, LLerena A, Terán E. Pharmacogenetics and Molecular Ancestry of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Ecuadorian Subjects with Type 2 Diabetes Mellitus. Pharmaceuticals. 2025; 18(9):1335. https://doi.org/10.3390/ph18091335

Ortega-Ayala, Adiel, Carla González de la Cruz, Lorena Mora, Mauro Bonilla, Leandro Tana, Fernanda Rodrigues-Soares, Pedro Dorado, Adrián LLerena, and Enrique Terán. 2025. "Pharmacogenetics and Molecular Ancestry of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Ecuadorian Subjects with Type 2 Diabetes Mellitus" Pharmaceuticals 18, no. 9: 1335. https://doi.org/10.3390/ph18091335

Ortega-Ayala, A., de la Cruz, C. G., Mora, L., Bonilla, M., Tana, L., Rodrigues-Soares, F., Dorado, P., LLerena, A., & Terán, E. (2025). Pharmacogenetics and Molecular Ancestry of SLC22A1, SLC22A2, SLC22A3, ABCB1, CYP2C8, CYP2C9, and CYP2C19 in Ecuadorian Subjects with Type 2 Diabetes Mellitus. Pharmaceuticals, 18(9), 1335. https://doi.org/10.3390/ph18091335